Novo Nordisk

Novo Nordisk says FDA disclosed focus of upcoming panel meeting
The Fly on the Wall
Fri, 10/26/12 - 10:32 am
FDA
advisory panels
Novo Nordisk
diabetes
degludec
FDA panel to weigh heart safety of Novo's new insulin
Reuters
Thu, 10/25/12 - 05:33 pm
advisory panels
FDA
Novo Nordisk
insulin
diabetes
degludec
Novo Nordisk: Encouraging Pipeline News
Seeking Alpha
Tue, 10/23/12 - 09:13 am
Novo Nordisk
Tresiba
Ryzodeg
diabetes
Novo's long-acting insulin degludec takes big step to megamarket status
Fierce Biotech
Fri, 10/19/12 - 12:20 pm
degludec
Novo Nordisk
diabetes
insulin
Europe
Tresiba
Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich
Seeking Alpha
Tue, 10/9/12 - 09:55 am
obesity
Novo Nordisk
Merck
Bristol-Myers Squibb
diabetes
Sanofi
Novo to Hire 1,000 People in 2 Years in Emerging Markets
Bloomberg Businessweek
Fri, 10/5/12 - 12:23 pm
emerging markets
diabetes
Novo Nordisk
Novo Says It’s Likely to Benefit From Bristol-Amylin Tie-Up
Bloomberg
Fri, 10/5/12 - 11:25 am
Bristol-Myers Squibb
Novo Nordisk
Amylin
diabetes
NVO's Tresiba Approved in Japan
Yahoo/Zacks
Thu, 10/4/12 - 10:39 am
Novo Nordisk
Tresiba
Japan
diabetes
Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Seeking Alpha
Wed, 10/3/12 - 10:50 am
patents
Bristol-Myers Squibb
Amylin
AstraZeneca
Novo Nordisk
Eli Lilly
Merck
Is Novo Nordisk the Perfect Stock?
Motley Fool
Sat, 09/29/12 - 11:51 am
Novo Nordisk
Novo Nordisk halts development of hemophilia drug
Reuters
Fri, 09/28/12 - 12:11 pm
Novo Nordisk
hemophilia
vatreptacog alfa
NovoSeven
Biogen, Shire, Novo top pharma ranking of shareholder value
Fierce Pharma
Tue, 09/18/12 - 12:54 pm
BiogenIdec
Shire
Novo Nordisk
The $47 Billion Hole in Pharma's Near-Term Future
Forbes
Tue, 09/4/12 - 10:53 am
Pfizer
Merck
Eli Lilly
Bristol-Myers Squibb
Novo Nordisk
emerging markets
generics
Novo Nordisk CFO Explains Winning Diabetes Strategy
Investors.com
Tue, 08/21/12 - 11:11 am
diabetes
Novo Nordisk
Novo Nordisk Still A Top-Notch Healthcare Growth Story
Seeking Alpha
Tue, 08/14/12 - 10:56 am
Novo Nordisk
AstraZeneca
Bristol-Myers Squibb
Sanofi
Eli Lilly
Diabetes drugs helps boost Novo Nordisk in Q2
Yahoo/AP
Thu, 08/9/12 - 11:56 am
earnings
Novo Nordisk
Novo raises targets on Victoza, insulin demand
Yahoo/Reuters
Thu, 08/9/12 - 11:35 am
Victoza
guidance
Novo Nordisk
insulin
Novo Nordisk And Johnson & Johnson Are Winners In Big Pharma
Seeking Alpha
Thu, 08/2/12 - 12:29 pm
JNJ
Novo Nordisk
Novo faces new hurdle in long-acting insulin race
Reuters
Wed, 07/18/12 - 11:52 am
Novo Nordisk
degludec
long-acting insulin
A Possible Bidding War For Human Genome Sciences, But Celgene Is The Real Gem
Seeking Alpha
Mon, 07/9/12 - 10:12 am
M&A
Human Genome Sciences
Celgene
Amylin
GSK
Novo Nordisk

Pages